Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial
PaperCitations, authors & open-access status
Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 65 citations, 2022 year and gold oa status.
65
Citations
2022
Year
gold
OA Status